Discrepancies between surveillance definition and the clinical incidence of Clostridium difficile infection in a veterans affairs long-term care facility

Infection Control and Hospital Epidemiology

Volumn 35, Issue 11, 2014, Pages 1435-1436

  Han, Alison ^a   Jump, Robin L P ^b,c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; VANCOMYCIN;

BACTERIUM DETECTION; CLINICAL EVALUATION; CLOSTRIDIUM DIFFICILE INFECTION; COMPARATIVE STUDY; DISEASE SURVEILLANCE; ENZYME IMMUNOASSAY; GENE; HEALTH CARE FACILITY; HUMAN; LABORATORY TEST; LETTER; LONG TERM CARE; NONHUMAN; POLYMERASE CHAIN REACTION; TOXIN B GENE;

EID: 84908330263     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1086/678434     Document Type: Letter

References (3)

1. Simor, AE, Bradley, SF, Strausbaugh, LJ, Crossley, K, Nicolle, LE. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 2002;23:696-703.
2. Centers for Disease Control and Prevention. Laboratory-identified multidrug-resistant organism (MDRO) and Clostridium difficile infection (CDI) events for long-term care facilities. 2012. http://www.cdc.gov/nhsn/PDFs/LTC/LTCF_LabID_Event_Protocol_FINAL_8-24-12.pdf. Accessed September 19, 2014.
3. Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-455.